We assessed the effects of mBMSC and EA on neurogenesis following ischemic stroke using cell proliferation markers (BrdU and Ki67) and differentiation makers (Sox2, Dcx, and PS-NCAM) in the SVZ and surrounding striatum and hippocampus, the main sites associated with general neurogenesis. The gene discussed is NCAM1; the disease is ischemic stroke.